Journal
MOLECULAR PSYCHIATRY
Volume 26, Issue 2, Pages 556-567Publisher
SPRINGERNATURE
DOI: 10.1038/s41380-019-0608-9
Keywords
-
Funding
- MRC [MR/R015724/1, MR/S005528/1, MR/K02308X/1, MR/N026063/1, MR/N025377/1] Funding Source: UKRI
- Medical Research Council [MR/N025377/1, MC_PC_12009, MR/K02308X/1, MR/M009041/1, MR/N026063/1, MR/S005528/1, MR/R015724/1] Funding Source: Medline
- Wellcome Trust [203151] Funding Source: Medline
- Department of Health Funding Source: Medline
Ask authors/readers for more resources
A novel approach was developed to deliver complex quaternary structure proteins transvascularly to rats, leading to neuropathological changes resembling the premotor stage of Parkinson's disease. This new delivery method could potentially be used for pathogenic and therapeutic protein cargos to the brain.
Parkinson's disease (PD) is an alpha-synucleinopathy characterized by the progressive loss of specific neuronal populations. Here, we develop a novel approach to transvascularly deliver proteins of complex quaternary structures, including alpha-synuclein preformed fibrils (pff). We show that a single systemic administration of alpha-synuclein pff triggers pathological transformation of endogenous alpha-synuclein in non-transgenic rats, which leads to neurodegeneration in discrete brain regions. Specifically, pff-exposed animals displayed a progressive deterioration in gastrointestinal and olfactory functions, which corresponded with the presence of cellular pathology in the central and enteric nervous systems. The alpha-synuclein pathology generated was both time dependent and region specific. Interestingly, the most significant neuropathological changes were observed in those brain regions affected in the early stages of PD. Our data therefore demonstrate for the first time that a single, transvascular administration of alpha-synuclein pff can lead to selective regional neuropathology resembling the premotor stage of idiopathic PD. Furthermore, this novel delivery approach could also be used to deliver a range of other pathogenic, as well as therapeutic, protein cargos transvascularly to the brain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available